Funder
The Second Hospital of Shanxi Medical University
Publisher
Springer Science and Business Media LLC
Subject
Immunology and Allergy,Rheumatology
Reference13 articles.
1. Barut K, Adrovic A, Sahin S, et al. Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience. Int J Rheum Dis. 2019;22(9):1661–9.
2. Adrovic A, Yildiz M, Köker O, Şahin S, Barut K, Kasapçopur Ö. Biologics in juvenile idiopathic arthritis—main advantages and major challenges: a narrative review. Arch Rheumatol. 2020;36(1):146–57.
3. Ravelli A, Consolaro A, Horneff G, et al. Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2018;77:819–28.
4. Massimo Gadina, Catrina Johnson, Daniella Schwartz, et al. Translational and clinical advances in JAK-STAT biology: the present and future of jakinibs. J Leukoc Biol. 2018;104:499–514.
5. Ruperto N, Brunner HI, Synoverska O, et al. Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG). Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial. Lancet. 2021;398(10315):1984–96.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献